Kiora Pharmaceuticals, Inc.

The momentum for this stock is not very good. Kiora Pharmaceuticals, Inc. is not a good value stock. Kiora Pharmaceuticals, Inc. is not a good growth stock. Tradey thinks it is not wise to invest in Kiora Pharmaceuticals, Inc. .

News

AIGH Capital Management LLC Sells 2,044,439 Shares of Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX)

Ticker Report AIGH Capital Management LLC cut its stake in shares of Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX - Free Report) by 88.9% in the 2nd quarter, according to the company in its most recent disclosure with...\n more…

Kiora Pharmaceuticals (NASDAQ:KPRX) Receives Buy Rating from HC Wainwright

Ticker Report HC Wainwright reaffirmed their buy rating on shares of Kiora Pharmaceuticals (NASDAQ:KPRX - Free Report) in a report released on Thursday, Benzinga reports. They currently have a $10.00 price target...\n more…

Kiora Pharmaceuticals (NASDAQ:KPRX) Shares Up 15.7%

Zolmax Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX - Get Free Report) shares rose 15.7% on Friday . The company traded as high as $3.89 and last traded at $3.76. Approximately 102,954 shares changed hands...\n more…

Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress

TipRanks Financial Blog Analyst Michael Okunewitch of Maxim Group maintained a Buy rating on Kiora Pharmaceuticals (KPRX - Research Report), with a price target of $27.00....\n more…

KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nKPRX stock results show that Kiora Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.\nThe post...\n more…